MedPath

The effect of Melatonin on the disability of multiple sclerosis patients

Phase 2
Conditions
Multiple Sclerosis.
Multiple sclerosis
Registration Number
IRCT2017072520258N55
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
58
Inclusion Criteria

multiple sclerosis with Mc.donald score; 18 to 50 years; ?expanded disability ?status scale (EDSS) 0 to 5.5?
Exclusion criteria: pregnancy; ?use pulse Corticosteroids drug in 6 months ago; side effect of drug; lack of ?routine monitoring of ?patients. ?

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
?disability. Timepoint: before treatment and 12 ?weeks after treatment. Method of measurement: Disability Status Scale (EDSS)?.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath